Board meeting on July 27 to approve Q1 FY27 results

Board & Shareholder Meetings View source PDF

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.2%1-day move

₹1406.00

prior close

₹1419.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.9-1.5-2.5-0.7-0.2-1.3-0.6———————

Up moveDown movePending

AI summary

Senores Pharmaceuticals has scheduled a Board meeting on Monday, July 27, 2026 to consider and approve its unaudited consolidated and standalone financial results for Q1 FY27, that is the quarter ended June 30, 2026. The trading window for insiders has been closed since July 1, 2026 and will reopen 48 hours after the results are filed with the stock exchanges.

Likely market impact

Q1 results announcement on July 27 may move the stock; insider trading window has been closed since July 1.